Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

Prognostic impact of C-REL expression in diffuse large B-cell lymphoma.

Curry CV, Ewton AA, Olsen RJ, Logan BR, Preti HA, Liu YC, Perkins SL, Chang CC.

J Hematop. 2009 Mar;2(1):20-6. doi: 10.1007/s12308-009-0021-4. Epub 2009 Feb 13.

2.

Evaluation of NF-κB subunit expression and signaling pathway activation demonstrates that p52 expression confers better outcome in germinal center B-cell-like diffuse large B-cell lymphoma in association with CD30 and BCL2 functions.

Ok CY, Xu-Monette ZY, Li L, Manyam GC, Montes-Moreno S, Tzankov A, Visco C, Dybkær K, Routbort MJ, Zhang L, Chiu A, Orazi A, Zu Y, Bhagat G, Richards KL, Hsi ED, Choi WW, van Krieken JH, Huh J, Ponzoni M, Ferreri AJ, Parsons BM, Rao H, Møller MB, Winter JN, Piris MA, Wang SA, Medeiros LJ, Young KH.

Mod Pathol. 2015 Sep;28(9):1202-13. doi: 10.1038/modpathol.2015.76. Epub 2015 Jun 26.

3.

[PROGNOSTIC ROLE OF NF-κB EXPRESSION IN DIFFUSE LARGE B-CELL LYMPHOMA SUBGROUPS].

Škunca Z, Planinc-Peraica A.

Acta Med Croatica. 2015 Mar;69(1):25-32. Croatian.

PMID:
26606782
4.

Prognostic impact of c-Rel nuclear expression and REL amplification and crosstalk between c-Rel and the p53 pathway in diffuse large B-cell lymphoma.

Li L, Xu-Monette ZY, Ok CY, Tzankov A, Manyam GC, Sun R, Visco C, Zhang M, Montes-Moreno S, Dybkaer K, Chiu A, Orazi A, Zu Y, Bhagat G, Richards KL, Hsi ED, Choi WW, van Krieken JH, Huh J, Ponzoni M, Ferreri AJ, Møller MB, Wang J, Parsons BM, Winter JN, Piris MA, Pham LV, Medeiros LJ, Young KH.

Oncotarget. 2015 Sep 15;6(27):23157-80.

5.
6.

Prognostic impact of germinal center-associated proteins and chromosomal breakpoints in poor-risk diffuse large B-cell lymphoma.

van Imhoff GW, Boerma EJ, van der Holt B, Schuuring E, Verdonck LF, Kluin-Nelemans HC, Kluin PM.

J Clin Oncol. 2006 Sep 1;24(25):4135-42.

PMID:
16943530
7.

Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray.

Hans CP, Weisenburger DD, Greiner TC, Gascoyne RD, Delabie J, Ott G, Müller-Hermelink HK, Campo E, Braziel RM, Jaffe ES, Pan Z, Farinha P, Smith LM, Falini B, Banham AH, Rosenwald A, Staudt LM, Connors JM, Armitage JO, Chan WC.

Blood. 2004 Jan 1;103(1):275-82. Epub 2003 Sep 22.

8.

[Subgrouping and outcome prediction of diffuse large B-cell lymphoma by immunohistochemistry].

Ye ZY, Cao YB, Lin TY, Lin HL.

Zhonghua Bing Li Xue Za Zhi. 2007 Oct;36(10):654-9. Chinese.

PMID:
18194597
9.

Lenalidomide combined with R-CHOP overcomes negative prognostic impact of non-germinal center B-cell phenotype in newly diagnosed diffuse large B-Cell lymphoma: a phase II study.

Nowakowski GS, LaPlant B, Macon WR, Reeder CB, Foran JM, Nelson GD, Thompson CA, Rivera CE, Inwards DJ, Micallef IN, Johnston PB, Porrata LF, Ansell SM, Gascoyne RD, Habermann TM, Witzig TE.

J Clin Oncol. 2015 Jan 20;33(3):251-7. doi: 10.1200/JCO.2014.55.5714. Epub 2014 Aug 18.

PMID:
25135992
10.

[Expression of CD68, cyclin D1 and rearrangement of bcl-6 gene are adverse prognostic factors in diffuse large B-cell lymphoma].

Liang X, Wang J, Bai W, Sun R.

Zhonghua Bing Li Xue Za Zhi. 2015 Aug;44(8):559-64. Chinese.

PMID:
26705179
11.

[Significance of CD138 in immunohistochemical profiles and its correlation with prognosis in diffuse large B-cell lymphoma].

Zhang HW, Chen ZW, Wang JF, Cheng NL.

Zhonghua Zhong Liu Za Zhi. 2011 Feb;33(2):115-20. Chinese.

PMID:
21575479
12.

Different predictive values of interim 18F-FDG PET/CT in germinal center like and non-germinal center like diffuse large B-cell lymphoma.

Kim J, Lee JO, Paik JH, Lee WW, Kim SE, Song YS.

Ann Nucl Med. 2017 Jan;31(1):1-11. doi: 10.1007/s12149-016-1123-6. Epub 2016 Sep 15.

PMID:
27627889
13.

[Nodal versus extranodal diffuse large B-cell lymphoma: comparison of clinicopathologic features, immunophenotype and prognosis].

Lu JB, Li XQ, Zhang PH, Zhou XY, Zhang TM, Li XM, Zhu XZ.

Zhonghua Bing Li Xue Za Zhi. 2007 Jul;36(7):470-3. Chinese.

PMID:
17845761
14.

Bcl-2 protein frequency in patients with high-risk diffuse large B-cell lymphoma.

Hallack Neto AE, Siqueira SA, Dulley FL, Chauobah A, Belesso M, Saboia R, Ruiz MA, Chamone DA, Pereira J.

Sao Paulo Med J. 2010 Jan;128(1):14-7.

15.

Immunophenotype classification and therapeutic outcomes of Chinese primary gastrointestinal diffuse large B-cell lymphoma.

Zhang Z, Shen Y, Shen D, Ni X.

BMC Gastroenterol. 2012 Jun 25;12:77. doi: 10.1186/1471-230X-12-77.

16.

[Immunophenotyping and molecular genetic analysis of diffuse large B-cell lymphoma].

Han YS, Xue YQ, Yang HY, Zhang J, Pan JL.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2013 Apr;30(2):143-7. doi: 10.3760/cma.j.issn.1003-9406.2013.04.004. Chinese.

PMID:
23568722
17.

Addition of rituximab to standard chemotherapy improves the survival of both the germinal center B-cell-like and non-germinal center B-cell-like subtypes of diffuse large B-cell lymphoma.

Fu K, Weisenburger DD, Choi WW, Perry KD, Smith LM, Shi X, Hans CP, Greiner TC, Bierman PJ, Bociek RG, Armitage JO, Chan WC, Vose JM.

J Clin Oncol. 2008 Oct 1;26(28):4587-94. doi: 10.1200/JCO.2007.15.9277. Epub 2008 Jul 28.

PMID:
18662967
18.

Primary diffuse large B-cell lymphoma of the oral cavity: germinal center classification.

Bhattacharyya I, Chehal HK, Cohen DM, Al-Quran SZ.

Head Neck Pathol. 2010 Sep;4(3):181-91. doi: 10.1007/s12105-010-0184-4. Epub 2010 Jun 9.

19.

BCL2 predicts survival in germinal center B-cell-like diffuse large B-cell lymphoma treated with CHOP-like therapy and rituximab.

Iqbal J, Meyer PN, Smith LM, Johnson NA, Vose JM, Greiner TC, Connors JM, Staudt LM, Rimsza L, Jaffe E, Rosenwald A, Ott G, Delabie J, Campo E, Braziel RM, Cook JR, Tubbs RR, Gascoyne RD, Armitage JO, Weisenburger DD, Chan WC.

Clin Cancer Res. 2011 Dec 15;17(24):7785-95. doi: 10.1158/1078-0432.CCR-11-0267. Epub 2011 Sep 20.

20.

[Primary gastrointestinal diffuse large B-cell lymphoma: an immunohistochemical and prognostic study of 90 cases].

Lin L, Min M, Bi CF, Wang XQ, Luo TY, Zhao S, Zhang WY, Liu WP.

Zhonghua Bing Li Xue Za Zhi. 2011 Apr;40(4):220-6. Chinese.

PMID:
21615994

Supplemental Content

Support Center